| Year |
Citation |
Score |
| 2020 |
Asem M, Young A, Oyama C, ClaureDeLaZerda A, Liu Y, Ravosa MJ, Gupta V, Jewell A, Khabele D, Stack MS. Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer. Scientific Reports. 10: 11913. PMID 32681052 DOI: 10.1038/s41598-020-68639-2 |
0.363 |
|
| 2020 |
Klymenko Y, Bos B, Campbell L, Loughran E, Liu Y, Yang J, Kim O, Stack MS. Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination. Scientific Reports. 10: 10877. PMID 32616784 DOI: 10.1038/S41598-020-67565-7 |
0.363 |
|
| 2020 |
Asem M, Young AM, Oyama C, Claure De La Zerda AG, Liu Y, Yang J, Hilliard TS, Johnson J, Harper EI, Guldner I, Zhang S, Page-Mayberry TM, Kaliney WJ, Stack MS. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis. Cancer Research. PMID 31932454 DOI: 10.1158/0008-5472.Can-19-1601 |
0.404 |
|
| 2018 |
Harper EI, Sheedy EF, Stack MS. With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment. Cancers. 10. PMID 29996539 DOI: 10.3390/cancers10070230 |
0.385 |
|
| 2018 |
Tang J, Pulliam N, Ozes A, Buechlein A, Ding N, Rusch D, Keer H, O'Hagan H, Stack MS, Nephew KP. EPIGENETIC TARGETING OF ADIPOCYTES INHIBITS HIGH-GRADE SEROUS OVARIAN CANCER CELL MIGRATION AND INVASION. Molecular Cancer Research : McR. PMID 29759990 DOI: 10.1158/1541-7786.Mcr-17-0406 |
0.388 |
|
| 2017 |
Klymenko Y, Kim O, Stack MS. Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer. Cancers. 9. PMID 28792442 DOI: 10.3390/Cancers9080104 |
0.428 |
|
| 2017 |
Yang J, Kasberg WC, Celo A, Liang Z, Quispe K, Stack MS. Post-Translational Modification of the Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Cytoplasmic Tail Impacts Ovarian Cancer Multicellular Aggregate Dynamics. The Journal of Biological Chemistry. PMID 28655772 DOI: 10.1074/jbc.M117.800904 |
0.644 |
|
| 2017 |
Klymenko Y, Kim O, Loughran E, Yang J, Lombard R, Alber M, Stack MS. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis. Oncogene. PMID 28628116 DOI: 10.1038/Onc.2017.171 |
0.626 |
|
| 2017 |
Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E, Stack MS. Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination. Neoplasia (New York, N.Y.). 19: 549-563. PMID 28601643 DOI: 10.1016/j.neo.2017.04.002 |
0.398 |
|
| 2016 |
Lewellen KA, Metzinger MN, Liu Y, Stack MS. Quantitation of Intra-peritoneal Ovarian Cancer Metastasis. Journal of Visualized Experiments : Jove. PMID 27500635 DOI: 10.3791/53316 |
0.315 |
|
| 2016 |
Bruney L, Liu Y, Grisoli A, Ravosa MJ, Stack MS. Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells. Oncotarget. PMID 26959113 DOI: 10.18632/oncotarget.7880 |
0.579 |
|
| 2016 |
Johnson JJ, Miller DL, Jiang R, Liu Y, Shi Z, Tarwater L, Williams R, Balsara R, Sauter ER, Stack MS. Protease Activated Receptor-2 (PAR-2)-Mediated Nf-κB Activation Suppresses Inflammation-Associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma. The Journal of Biological Chemistry. PMID 26839311 DOI: 10.1074/jbc.M115.692640 |
0.335 |
|
| 2014 |
Bruney L, Conley KC, Moss NM, Liu Y, Stack MS. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium. Biological Chemistry. 395: 1221-31. PMID 25205731 DOI: 10.1515/Hsz-2014-0155 |
0.744 |
|
| 2014 |
Johnson J, Shi Z, Liu Y, Stack MS. Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma. Oral Oncology. 50: 468-77. PMID 24582884 DOI: 10.1016/j.oraloncology.2014.02.004 |
0.304 |
|
| 2014 |
Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP, Hales DB, Stack MS. Epithelial ovarian cancer experimental models. Oncogene. 33: 3619-33. PMID 23934194 DOI: 10.1038/Onc.2013.321 |
0.339 |
|
| 2013 |
Barbolina MV, Liu Y, Gurler H, Kim M, Kajdacsy-Balla AA, Rooper L, Shepard J, Weiss M, Shea LD, Penzes P, Ravosa MJ, Stack MS. Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein. The Journal of Biological Chemistry. 288: 141-51. PMID 23152495 DOI: 10.1074/Jbc.M112.431411 |
0.515 |
|
| 2012 |
Liu Y, Burkhalter R, Symowicz J, Chaffin K, Ellerbroek S, Stack MS. Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells. Journal of Oncology. 2012: 501492. PMID 22593767 DOI: 10.1155/2012/501492 |
0.5 |
|
| 2012 |
Dong Y, He Y, de Boer L, Stack MS, Lumley JW, Clements JA, Hooper JD. The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration. The Journal of Biological Chemistry. 287: 9792-803. PMID 22315226 DOI: 10.1074/jbc.M111.335448 |
0.379 |
|
| 2011 |
Shi Z, Liu Y, Johnson JJ, Stack MS. Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas. Molecular and Cellular Biochemistry. 357: 151-61. PMID 21630091 DOI: 10.1007/s11010-011-0885-3 |
0.446 |
|
| 2011 |
Burkhalter RJ, Symowicz J, Hudson LG, Gottardi CJ, Stack MS. Integrin regulation of beta-catenin signaling in ovarian carcinoma. The Journal of Biological Chemistry. 286: 23467-75. PMID 21518759 DOI: 10.1074/Jbc.M110.199539 |
0.431 |
|
| 2011 |
Jiang R, Shi Z, Johnson JJ, Liu Y, Stack MS. Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. The Journal of Biological Chemistry. 286: 9127-35. PMID 21163944 DOI: 10.1074/jbc.M110.191361 |
0.372 |
|
| 2010 |
Shi Z, Stack MS. Molecules of cell adhesion and extracellular matrix proteolysis in oral squamous cell carcinoma. Histology and Histopathology. 25: 917-32. PMID 20503180 |
0.441 |
|
| 2010 |
Barbolina MV, Kim M, Liu Y, Shepard J, Belmadani A, Miller RJ, Shea LD, Stack MS. Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma. Molecular Cancer Research : McR. 8: 653-64. PMID 20460402 DOI: 10.1158/1541-7786.Mcr-09-0463 |
0.558 |
|
| 2010 |
Ghosh S, Koblinski J, Johnson J, Liu Y, Ericsson A, Davis JW, Shi Z, Ravosa MJ, Crawford S, Frazier S, Stack MS. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression. Molecular Cancer Research : McR. 8: 145-58. PMID 20145038 DOI: 10.1158/1541-7786.Mcr-09-0045 |
0.358 |
|
| 2009 |
Barbolina MV, Moss NM, Westfall SD, Liu Y, Burkhalter RJ, Marga F, Forgacs G, Hudson LG, Stack MS. Microenvironmental regulation of ovarian cancer metastasis. Cancer Treatment and Research. 149: 319-34. PMID 19763443 DOI: 10.1007/978-0-387-98094-2_15 |
0.688 |
|
| 2009 |
Moss NM, Barbolina MV, Liu Y, Sun L, Munshi HG, Stack MS. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination. Cancer Research. 69: 7121-9. PMID 19706774 DOI: 10.1158/0008-5472.Can-08-4151 |
0.764 |
|
| 2009 |
Moss NM, Liu Y, Johnson JJ, Debiase P, Jones J, Hudson LG, Munshi HG, Stack MS. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen. Molecular Cancer Research : McR. 7: 809-20. PMID 19509114 DOI: 10.1158/1541-7786.Mcr-08-0571 |
0.76 |
|
| 2009 |
Moss NM, Wu YI, Liu Y, Munshi HG, Stack MS. Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices. The Journal of Biological Chemistry. 284: 19791-9. PMID 19458085 DOI: 10.1074/Jbc.M109.020362 |
0.738 |
|
| 2009 |
Barbolina MV, Adley BP, Kelly DL, Shepard J, Fought AJ, Scholtens D, Penzes P, Shea LD, Stack MS. Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion. International Journal of Cancer. Journal International Du Cancer. 125: 816-25. PMID 19382180 DOI: 10.1002/Ijc.24347 |
0.519 |
|
| 2009 |
Hudson LG, Moss NM, Stack MS. EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma. Future Oncology (London, England). 5: 323-38. PMID 19374540 DOI: 10.2217/Fon.09.10 |
0.725 |
|
| 2009 |
Pettus JR, Johnson JJ, Shi Z, Davis JW, Koblinski J, Ghosh S, Liu Y, Ravosa MJ, Frazier S, Stack MS. Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity. Histology and Histopathology. 24: 197-207. PMID 19085836 DOI: 10.14670/Hh-24.197 |
0.346 |
|
| 2009 |
Adley BP, Gleason KJ, Yang XJ, Stack MS. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma. Gynecologic Oncology. 112: 319-24. PMID 18976802 DOI: 10.1016/j.ygyno.2008.09.025 |
0.671 |
|
| 2008 |
Woo MM, Salamanca CM, Symowicz J, Stack MS, Miller DM, Leung PC, Gilks CB, Auersperg N. SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells. Gynecologic Oncology. 111: 125-31. PMID 18678400 DOI: 10.1016/J.Ygyno.2008.06.021 |
0.439 |
|
| 2008 |
Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, Adley BP, Stack MS, Hudson LG. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Research. 68: 4606-13. PMID 18559505 DOI: 10.1158/0008-5472.Can-07-5046 |
0.578 |
|
| 2008 |
Wang C, Norton JT, Ghosh S, Kim J, Fushimi K, Wu JY, Stack MS, Huang S. Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner. The Journal of Biological Chemistry. 283: 20277-87. PMID 18499661 DOI: 10.1074/Jbc.M803682200 |
0.355 |
|
| 2008 |
Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clinical & Experimental Metastasis. 25: 643-55. PMID 18398687 DOI: 10.1007/S10585-008-9171-5 |
0.43 |
|
| 2008 |
Barbolina MV, Adley BP, Kelly DL, Fought AJ, Scholtens DM, Shea LD, Stack MS. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 602-14. PMID 18362906 DOI: 10.1038/Labinvest.2008.25 |
0.428 |
|
| 2008 |
Barbolina MV, Adley BP, Shea LD, Stack MS. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer. 112: 1632-41. PMID 18260155 DOI: 10.1002/Cncr.23341 |
0.49 |
|
| 2008 |
Barbolina MV, Stack MS. Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Seminars in Cell & Developmental Biology. 19: 24-33. PMID 17702616 DOI: 10.1016/j.semcdb.2007.06.008 |
0.516 |
|
| 2007 |
Shi Z, Stack MS. Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity. The Biochemical Journal. 407: 153-9. PMID 17880283 DOI: 10.1042/BJ20071037 |
0.315 |
|
| 2007 |
Wu YI, Munshi HG, Snipas SJ, Salvesen GS, Fridman R, Stack MS. Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking. The Biochemical Journal. 407: 171-7. PMID 17650075 DOI: 10.1042/Bj20070552 |
0.512 |
|
| 2007 |
Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nature Cell Biology. 9: 893-904. PMID 17618273 DOI: 10.1038/Ncb1616 |
0.578 |
|
| 2007 |
Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, Fishman DA, Hudson LG, Stack MS. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Research. 67: 2030-9. PMID 17332331 DOI: 10.1158/0008-5472.Can-06-2808 |
0.594 |
|
| 2007 |
Do TV, Symowicz JC, Berman DM, Liotta LA, Petricoin EF, Stack MS, Fishman DA. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. Molecular Cancer Research : McR. 5: 121-31. PMID 17314270 DOI: 10.1158/1541-7786.MCR-06-0319 |
0.561 |
|
| 2007 |
Barbolina MV, Adley BP, Ariztia EV, Liu Y, Stack MS. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression. The Journal of Biological Chemistry. 282: 4924-31. PMID 17158885 DOI: 10.1074/jbc.M608428200 |
0.64 |
|
| 2006 |
Zeineldin R, Rosenberg M, Ortega D, Buhr C, Chavez MG, Stack MS, Kusewitt DF, Hudson LG. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III. Molecular Carcinogenesis. 45: 851-60. PMID 16788982 DOI: 10.1002/Mc.20237 |
0.413 |
|
| 2006 |
Munshi HG, Stack MS. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Reviews. 25: 45-56. PMID 16680571 DOI: 10.1007/S10555-006-7888-7 |
0.521 |
|
| 2006 |
Ghosh S, Johnson JJ, Sen R, Mukhopadhyay S, Liu Y, Zhang F, Wei Y, Chapman HA, Stack MS. Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways. The Journal of Biological Chemistry. 281: 13021-9. PMID 16510444 DOI: 10.1074/jbc.M508526200 |
0.329 |
|
| 2005 |
Ning Y, Zeineldin R, Liu Y, Rosenberg M, Stack MS, Hudson LG. Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation. Cancer Research. 65: 9280-6. PMID 16230389 DOI: 10.1158/0008-5472.Can-05-0407 |
0.378 |
|
| 2005 |
Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Research. 65: 2234-42. PMID 15781636 DOI: 10.1158/0008.5472.Can-04-2781 |
0.601 |
|
| 2004 |
Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Research. 64: 7045-9. PMID 15466198 DOI: 10.1158/0008-5472.CAN-04-1800 |
0.552 |
|
| 2004 |
Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, Koblinski JE, Platanias LC, Stack MS. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. The Journal of Biological Chemistry. 279: 39042-50. PMID 15247230 DOI: 10.1074/Jbc.M404958200 |
0.572 |
|
| 2004 |
Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, Stack MS, Green KJ. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. The Journal of Biological Chemistry. 279: 37191-200. PMID 15205458 DOI: 10.1074/Jbc.M405123200 |
0.369 |
|
| 2004 |
Mukhopadhyay S, Munshi HG, Kambhampati S, Sassano A, Platanias LC, Stack MS. Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma. The Journal of Biological Chemistry. 279: 33139-46. PMID 15180997 DOI: 10.1074/Jbc.M405194200 |
0.47 |
|
| 2004 |
Tam EM, Morrison CJ, Wu YI, Stack MS, Overall CM. Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proceedings of the National Academy of Sciences of the United States of America. 101: 6917-22. PMID 15118097 DOI: 10.1073/Pnas.0305862101 |
0.518 |
|
| 2004 |
DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. The American Journal of Pathology. 164: 1131-9. PMID 15039201 DOI: 10.1016/S0002-9440(10)63200-2 |
0.446 |
|
| 2004 |
Wu YI, Munshi HG, Sen R, Snipas SJ, Salvesen GS, Fridman R, Stack MS. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. The Journal of Biological Chemistry. 279: 8278-89. PMID 14670950 DOI: 10.1074/Jbc.M311870200 |
0.589 |
|
| 2003 |
Lauer-Fields JL, Sritharan T, Stack MS, Nagase H, Fields GB. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. The Journal of Biological Chemistry. 278: 18140-5. PMID 12642591 DOI: 10.1074/Jbc.M211330200 |
0.536 |
|
| 2002 |
Ghosh S, Munshi HG, Sen R, Linz-McGillem LA, Goldman RD, Lorch J, Green KJ, Jones JC, Stack MS. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma. Cancer. 95: 2524-33. PMID 12467066 DOI: 10.1002/Cncr.10997 |
0.446 |
|
| 2002 |
Munshi HG, Wu YI, Ariztia EV, Stack MS. Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells. The Journal of Biological Chemistry. 277: 41480-8. PMID 12194986 DOI: 10.1074/Jbc.M207695200 |
0.581 |
|
| 2002 |
Tam EM, Wu YI, Butler GS, Stack MS, Overall CM. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage. The Journal of Biological Chemistry. 277: 39005-14. PMID 12145314 DOI: 10.1074/Jbc.M206874200 |
0.562 |
|
| 2002 |
Munshi HG, Ghosh S, Mukhopadhyay S, Wu YI, Sen R, Green KJ, Stack MS. Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes. The Journal of Biological Chemistry. 277: 38159-67. PMID 12138162 DOI: 10.1074/Jbc.M202384200 |
0.384 |
|
| 2002 |
Munshi HG, Stack MS. Analysis of matrix degradation. Methods in Cell Biology. 69: 195-205. PMID 12070993 DOI: 10.1016/S0091-679X(02)69013-2 |
0.452 |
|
| 2002 |
Mills GB, Eder A, Fang X, Hasegawa Y, Mao M, Lu Y, Tanyi J, Tabassam FH, Wiener J, Lapushin R, Yu S, Parrott JA, Compton T, Tribley W, Fishman D, ... Stack MS, et al. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treatment and Research. 107: 259-83. PMID 11775454 |
0.3 |
|
| 2001 |
Ellerbroek SM, Wu YI, Stack MS. Type I collagen stabilization of matrix metalloproteinase-2. Archives of Biochemistry and Biophysics. 390: 51-6. PMID 11368514 DOI: 10.1006/Abbi.2001.2345 |
0.538 |
|
| 2001 |
Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. The Journal of Biological Chemistry. 276: 24833-42. PMID 11331272 DOI: 10.1074/Jbc.M005631200 |
0.559 |
|
| 2001 |
Fishman DA, Liu Y, Ellerbroek SM, Stack MS. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Research. 61: 3194-9. PMID 11306508 |
0.647 |
|
| 2001 |
Ellerbroek SM, Halbleib JM, Benavidez M, Warmka JK, Wattenberg EV, Stack MS, Hudson LG. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Research. 61: 1855-61. PMID 11280738 |
0.565 |
|
| 2001 |
Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast RC, Stack MS. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecologic Oncology. 80: 245-53. PMID 11161867 DOI: 10.1006/Gyno.2000.6042 |
0.492 |
|
| 2000 |
Goldfinger LE, Jiang L, Hopkinson SB, Stack MS, Jones JC. Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha 3 subunit of laminin-5. The Journal of Biological Chemistry. 275: 34887-93. PMID 10956663 DOI: 10.1074/jbc.M006652200 |
0.302 |
|
| 1999 |
Ellerbroek SM, Stack MS. Membrane associated matrix metalloproteinases in metastasis. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 21: 940-9. PMID 10517867 DOI: 10.1002/(Sici)1521-1878(199911)21:11<940::Aid-Bies6>3.0.Co;2-J |
0.592 |
|
| 1999 |
Fishman DA, Kearns A, Larsh S, Enghild JJ, Stack MS. Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment. The Biochemical Journal. 341: 765-9. PMID 10417342 DOI: 10.1042/0264-6021:3410765 |
0.469 |
|
| 1999 |
Stack MS, Gately S, Bafetti LM, Enghild JJ, Soff GA. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. The Biochemical Journal. 340: 77-84. PMID 10229661 DOI: 10.1042/0264-6021:3400077 |
0.35 |
|
| 1999 |
Ellerbroek SM, Fishman DA, Kearns AS, Bafetti LM, Stack MS. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Research. 59: 1635-41. PMID 10197640 |
0.545 |
|
| 1998 |
Fishman DA, Kearns A, Chilukuri K, Bafetti LM, O'Toole EA, Georgacopoulos J, Ravosa MJ, Stack MS. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen. Invasion & Metastasis. 18: 15-26. PMID 10207247 |
0.522 |
|
| 1998 |
Ellerbroek SM, Hudson LG, Stack MS. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion. International Journal of Cancer. Journal International Du Cancer. 78: 331-7. PMID 9766568 DOI: 10.1002/(Sici)1097-0215(19981029)78:3<331::Aid-Ijc13>3.0.Co;2-9 |
0.601 |
|
| 1998 |
Rao CN, Cook B, Liu Y, Chilukuri K, Stack MS, Foster DC, Kisiel W, Woodley DT. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI. International Journal of Cancer. Journal International Du Cancer. 76: 749-56. PMID 9610735 DOI: 10.1002/(SICI)1097-0215(19980529)76:5<749::AID-IJC21>3.0.CO;2-Y |
0.496 |
|
| 1998 |
Goldfinger LE, Stack MS, Jones JC. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. The Journal of Cell Biology. 141: 255-65. PMID 9531563 DOI: 10.1083/jcb.141.1.255 |
0.375 |
|
| 1998 |
Stack MS, Ellerbroek SM, Fishman DA. The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. International Journal of Oncology. 12: 569-76. PMID 9472094 DOI: 10.3892/Ijo.12.3.569 |
0.49 |
|
| 1998 |
Bafetti LM, Young TN, Itoh Y, Stack MS. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. The Journal of Biological Chemistry. 273: 143-9. PMID 9417058 DOI: 10.1074/jbc.273.1.143 |
0.584 |
|
| 1997 |
Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N, Soff GA. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proceedings of the National Academy of Sciences of the United States of America. 94: 10868-72. PMID 9380726 DOI: 10.1073/Pnas.94.20.10868 |
0.353 |
|
| 1997 |
Fishman DA, Chilukuri K, Stack MS. Biochemical characterization of primary peritoneal carcinoma cell adhesion, migration, and proteinase activity. Gynecologic Oncology. 67: 193-9. PMID 9367707 DOI: 10.1006/gyno.1997.4850 |
0.574 |
|
| 1997 |
Fishman DA, Bafetti LM, Banionis S, Kearns AS, Chilukuri K, Stack MS. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer. 80: 1457-63. PMID 9338470 DOI: 10.1002/(SICI)1097-0142(19971015)80:8<1457::AID-CNCR13>3.0.CO;2-4 |
0.61 |
|
| 1996 |
Stack MS, Itoh Y, Young TN, Nagase H. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation. Archives of Biochemistry and Biophysics. 333: 163-9. PMID 8806767 DOI: 10.1006/Abbi.1996.0377 |
0.506 |
|
| 1996 |
Moser TL, Pizzo SV, Bafetti LM, Fishman DA, Stack MS. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin. International Journal of Cancer. Journal International Du Cancer. 67: 695-701. PMID 8782661 DOI: 10.1002/(Sici)1097-0215(19960904)67:5<695::Aid-Ijc18>3.0.Co;2-4 |
0.55 |
|
| 1996 |
Young TN, Rodriguez GC, Rinehart AR, Bast RC, Pizzo SV, Stack MS. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2. Gynecologic Oncology. 62: 89-99. PMID 8690299 DOI: 10.1006/Gyno.1996.0195 |
0.66 |
|
| 1995 |
Young TN, Pizzo SV, Stack MS. A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2. The Journal of Biological Chemistry. 270: 999-1002. PMID 7836420 DOI: 10.1074/Jbc.270.3.999 |
0.547 |
|
| 1994 |
Young TN, Rodriguez GC, Moser TL, Bast RC, Pizzo SV, Stack MS. Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium. American Journal of Obstetrics and Gynecology. 170: 1285-96. PMID 8178854 DOI: 10.1016/S0002-9378(94)70143-1 |
0.385 |
|
| 1994 |
Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RC, Stack MS. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. International Journal of Cancer. Journal International Du Cancer. 56: 552-9. PMID 8112891 DOI: 10.1002/Ijc.2910560415 |
0.529 |
|
| 1994 |
Youna TN, Moser TL, Rodriguez GC, Bast RC, Pizzo SV, Stack M. Regulation of ovarian carcinoma-associaited proteinases: Cell surface-mediated proteolysis by plasma membrane localized matrix metalloproteinase-2 and urinary-type plasminogen activator Fibrinolysis. 8: 56. DOI: 10.1016/0268-9499(94)90440-5 |
0.473 |
|
| 1991 |
Stack MS, Emberts CG, Gray RD. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin. Archives of Biochemistry and Biophysics. 287: 240-9. PMID 1654808 DOI: 10.1016/0003-9861(91)90413-D |
0.526 |
|
| Show low-probability matches. |